Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis
- 12 February 2009
- journal article
- research article
- Published by Elsevier BV in Epilepsy Research
- Vol. 84 (2-3), 238-241
- https://doi.org/10.1016/j.eplepsyres.2009.01.002
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Silk polymer-based adenosine release: Therapeutic potential for epilepsyBiomaterials, 2008
- Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responsesProceedings of the National Academy of Sciences of the United States of America, 2008
- Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti‐inflammatory actionGlia, 2008
- Cell and gene therapies in epilepsy – promising avenues or blind alleys?Trends in Neurosciences, 2008
- Cell therapy in models for temporal lobe epilepsySeizure, 2007
- Concise Review: Prospects of Stem Cell Therapy for Temporal Lobe EpilepsyThe International Journal of Cell Cloning, 2007
- Cell and gene therapies for refractory epilepsy.Current Neuropharmacology, 2007
- Adenosine-Based Cell Therapy Approaches for Pharmacoresistant EpilepsiesNeurodegenerative Diseases, 2007
- Neuroprotection in Ischemic Mouse Brain Induced by Stem Cell-Derived Brain ImplantsJournal of Cerebral Blood Flow & Metabolism, 2006
- The support of adenosine release from adenosine kinase deficient ES cells by silk substratesBiomaterials, 2006